SEC Form D · filed January 2, 2019
Navitor Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Thomas P. Hughes · Cambridge, MAExec · DirectorDavid P. Madden · Cambridge, MADirectorVinzenz P. Ploerer · Cambridge, MADirectorAlan P. Crane · Cambridge, MADirectorKevin P. Bitterman · Cambridge, MADirectorMarian P. Nakada, Ph.D · Cambridge, MADirectorRick P. Lundberg · Cambridge, MAExecJohn P. Creecy · Cambridge, MADirectorDonald E. Conrad · Islandia, NYDirectorGeorge P. Vlasuk · Cambridge, MAExec · DirectorRajeev P. Dadoo · Cambridge, MADirectorDavid Icikson · New York, NYExecJonathan Neiss · NEW YORK, NYDirectorJosh Curry · Frisco, TXDirectorEkta S. Dang · Fremont, CADirectorCatenary Carbon GP, LLC · Miami, FLDirectorChadwick J. Wasilenkoff · Indio, CAExec · DirectorSeth Lax · NEW YORK, NYExec · DirectorAaron Katz · New York, NYDirectorMelissa S. Miller · North Charleston, SCDirectorBrenda Smith · Conshohocken, PAExecPawel Gierynski · Warsaw, R9DirectorStephen Richmond · Warsaw, R9DirectorNeil Milne · Warsaw, R9Exec · DirectorWilliam Manby · Akron, OHDirectorTullis Growth Partners Ii, L.L.C · PALM BEACH GARDENS, FLDirectorWilliam Warren · Lorton, VADirectorThomas L. Tuttle · New York, NYDirectorMichael Levenberg · Philadelphia, PADirectorSeth Lehr · Philadelphia, PAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗